What if there was a way to harness all this data we’re collecting and turn it into a strategic advantage for our clinical trials? Indeed, Biorasi’s data sciences team has found a way. Methods beyond risk-based monitoring are required for a more comprehensive yet efficient clinical trial monitoring approach.
Site selection is one of the most crucial parts of planning a study. Ensuring that sites are performing up to par while a trial is underway is equally important but often neglected. Biorasi was asked to assist in a phase II trial of stem cell therapy for traumatic brain injury (TBI).
Every clinical trial comes with its own unique challenges. Sometimes the biggest challenge faced by a […]
Challenges in clinical trial recruitment are particularly prevalent in PD studies of disease modification, where the population of interest is difficult to find and study design is more complex. In fact, a recent PD clinical study showed that 55.6% of sites fell below projected recruitment goals.
Clinical trials in neurological diseases present a wide range of challenges and special considerations across the board. With the right experienced study team, a patient and disease pathobiology disease centered study process can be applied to mitigate many of those challenges.
An outside rescue expert can bring a fresh set of eyes to a troubled study and help you identify the true root causes of the failure. They can also find more cost-effective and efficient ways to implement some of the strategies you were planning to implement internally, resulting in a net savings.
Patient compliance was a serious concern, particularly regarding the reduction of sun exposure. Running a dermatology trial, especially in the middle of summer, can greatly affect patient compliance and the resulting, potential flare-ups in any dermatological condition.
Intelligent Project Management to the Rescue of a Scabies Generic Trial
Strict Processes Rescue Complex MS Trial: Biorasi’s Project Management-first Approach Allows Rapid Feasibility and Site Startup to Meet Critical Deadlines
Clinical trials are complex undertakings, with complex planning required. Success or failure is often determined long before the trial even gets underway. Biorasi’s quintessential guide to clinical trial planning helps program managers and operations directors identify and resolve the sticking points that can risk the timely completion of their clinical trials and programs.
It is estimated that the number of PD cases is likely to grow significantly as populations grow older around the world and it is predicted that PD prevalence will at least double by 2030 in the US alone. As a result, it has become increasingly clear that these novel PD treatments and others need to be advancing to reach the clinical realm.
A Modern Approach to Patient Education Increases Enrollment
